{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T15:52:51Z","timestamp":1761580371632},"reference-count":13,"publisher":"Springer Science and Business Media LLC","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Drug Safety"],"published-print":{"date-parts":[[2002]]},"DOI":"10.2165\/00002018-200225110-00005","type":"journal-article","created":{"date-parts":[[2006,1,21]],"date-time":"2006-01-21T11:39:50Z","timestamp":1137843590000},"page":"811-821","source":"Crossref","is-referenced-by-count":10,"title":["Comparison of Losartan with ACE Inhibitors and Dihydropyridine Calcium Channel Antagonists"],"prefix":"10.2165","volume":"25","author":[{"given":"Kazuo","family":"Samizo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eri","family":"Kawabe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shiro","family":"Hinotsu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tsugumichi","family":"Sato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shigeru","family":"Kageyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chikuma","family":"Hamada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuo","family":"Ohashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kiyoshi","family":"Kubota","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"R1-5","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1002\/(SICI)1099-1557(199910\/11)8:6<447::AID-PDS446>3.0.CO;2-I","volume":"8","author":"Kubota","year":"1999","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"R2-5","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1007\/s002280000232","volume":"56","author":"Kubota","year":"2001","journal-title":"Eur J Clin Pharmacol"},{"key":"R3-5","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1002\/pds.642","volume":"10","author":"Tanaka","year":"2001","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"6","key":"R4-5","doi-asserted-by":"crossref","first-page":"441","DOI":"10.2165\/00002018-200225060-00008","volume":"25","author":"Kubota","year":"2002","journal-title":"Drug Saf"},{"key":"R5-5","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1345\/aph.17388","volume":"32","author":"Pylypchuc","year":"1998","journal-title":"Ann Pharmacother"},{"key":"R6-5","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1093\/ajhp\/56.9.914","volume":"56","author":"Conigliaro","year":"1999","journal-title":"Am J Health Syst Pharm"},{"key":"R7-5","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1016\/S0091-6749(96)80205-3","volume":"98","author":"Dicpinigaitis","year":"1996","journal-title":"J Allergy Clin Immunol"},{"key":"R8-5","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1038\/sj.jhh.1000880","volume":"13","author":"Mann","year":"1999","journal-title":"J Hum Hypertens"},{"key":"R9-5","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1046\/j.1365-2125.1999.00855.x","volume":"47","author":"Makay","year":"1999","journal-title":"Br J Clin Pharmacol"},{"key":"R11-5","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S1386-5056(00)00062-9","volume":"57","author":"Yokotsuka","year":"2000","journal-title":"Int J Med Inf"},{"key":"R14-5","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1016\/S0140-6736(00)02799-9","volume":"356","author":"Edwards","year":"2000","journal-title":"Lancet"},{"key":"R15-5","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1007\/BF00196104","volume":"46","author":"Kubota","year":"1994","journal-title":"Eur J Clin Pharmacol"},{"key":"R16-5","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1136\/bmj.282.6271.1216","volume":"282","author":"Inman","year":"1981","journal-title":"BMJ"}],"container-title":["Drug Safety"],"original-title":[],"language":"en","deposited":{"date-parts":[[2019,3,21]],"date-time":"2019-03-21T15:27:27Z","timestamp":1553182047000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.2165\/00002018-200225110-00005"}},"subtitle":["A Pilot Study of Prescription-Event Monitoring in Japan"],"short-title":[],"issued":{"date-parts":[[2002]]},"references-count":13,"journal-issue":{"issue":"11"},"URL":"https:\/\/doi.org\/10.2165\/00002018-200225110-00005","relation":{},"ISSN":["0114-5916"],"issn-type":[{"value":"0114-5916","type":"print"}],"subject":[],"published":{"date-parts":[[2002]]}}}